The latest FDA warning was issued in response to alarming findings from a recent inspection of an as yet unidentified eye drop manufacturing facility.
Following the February outbreak, the FDA provided a comprehensive account of nonsterile conditions at a manufacturing facility in India that made the eye drop products sold in the U.S.
[
Collection
]
[
|
...
]